Literature DB >> 23277383

Risk, Russian-roulette and lotteries: Persson and Savulescu on moral enhancement.

Darryl Gunson1, Hugh McLachlan.   

Abstract

The literature concerning the possibility and desirability of using new pharmacological and possible future genetic techniques to enhance human characteristics is well-established and the debates follow some well-known argumentative patterns. However, one argument in particular stands out and demands attention. This is the attempt to tie the moral necessity of moral enhancement to the hypothesised risks that allowing cognitive enhancement will bring. According to Persson and Savulescu, cognitive enhancement should occur only if the risks they think it to poses are mitigated by moral enhancement. By this they mean the compulsory and universal amplification of the disposition of altruism and the inflation of our sense of fairness, by chemical and/or genetic means. Their claim is important, intriguing and unsettling. This paper focuses on three central, but relatively neglected, features of their argument. First, there is a pernicious ambiguity in the language of 'risk' used by Persson and Savulescu where they tend to conflate 'risk' and 'uncertainty'. Second, their use of the lottery analogy to render their position more plausible is unconvincing. It tends to distort rather than illuminate the relevant considerations. Third, Persson and Savulescu do not adequately take into account the social and individual benefits that enhancing cognition could have. If they did, it would be apparent that those benefits alone would outweigh the considerations used to justify accompanying CE with ME.

Entities:  

Mesh:

Year:  2013        PMID: 23277383     DOI: 10.1007/s11019-012-9461-1

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  16 in total

1.  'Ethics is for bad guys!' Putting the 'moral' into moral enhancement.

Authors:  John Harris
Journal:  Bioethics       Date:  2012-02-02       Impact factor: 1.898

2.  Evaluating the risks of clinical research.

Authors:  Annette Rid; Ezekiel J Emanuel; David Wendler
Journal:  JAMA       Date:  2010-10-06       Impact factor: 56.272

3.  Neuroethics.

Authors:  Walter Glannon
Journal:  Bioethics       Date:  2006-02       Impact factor: 1.898

Review 4.  Progress and prospects: gene therapy for performance and appearance enhancement.

Authors:  M Kiuru; R G Crystal
Journal:  Gene Ther       Date:  2008-01-24       Impact factor: 5.250

5.  Cognitive enhancing effects of modafinil in healthy volunteers.

Authors:  Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2002-11-01       Impact factor: 4.530

6.  Enhancing cognition after stress with gene therapy.

Authors:  Andrea Nicholas; Carolina D Munhoz; Deveroux Ferguson; Laura Campbell; Robert Sapolsky
Journal:  J Neurosci       Date:  2006-11-08       Impact factor: 6.167

7.  Effects of modafinil on working memory processes in humans.

Authors:  Ulrich Müller; Nikolai Steffenhagen; Ralf Regenthal; Peter Bublak
Journal:  Psychopharmacology (Berl)       Date:  2004-06-24       Impact factor: 4.530

8.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

9.  Moral enhancement and freedom.

Authors:  John Harris
Journal:  Bioethics       Date:  2010-12-07       Impact factor: 1.898

10.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.

Authors:  Thomas Roth; Gregory A Rippon; Sanjay Arora
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

View more
  1 in total

Review 1.  The ethical desirability of moral bioenhancement: a review of reasons.

Authors:  Jona Specker; Farah Focquaert; Kasper Raus; Sigrid Sterckx; Maartje Schermer
Journal:  BMC Med Ethics       Date:  2014-09-16       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.